Patent · US Active

Treatment for pancreatic cancer

US9642856B2 · kind B2 · utility

5Cited by
15References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 3, 2014
Grant dateMay 9, 2017
Priority date
Expiry dateOct 3, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention is related to a method of treating a subject with pancreatic cancer with administration of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.